Have a Claim?

Click here for a confidential contact or call:


July 24, 2017

Posted  August 8, 2017

Tennessee-based Pain Management Group P.C. agreed to pay $312,000 to settle charges it violated the False Claims Act by billing for medically unnecessary urine drug tests and non-FDA approved pharmaceuticals Botox, Supartz, and Eufflexa, which the company purchased from foreign-based suppliers.  DOJ (MDTN)

Tagged in: Healthcare Fraud, Medicare, Provider Fraud,